0 CHECKOUT

Risk-to-Price Commentary: Rautaruukki Oyj Feb 11

  • ID: 1711894
  • February 2011
  • Standard & Poors

FEATURED COMPANIES

  • Arcelor S.A.
  • ArcelorMittal Finance
  • BHP Billiton Finance Ltd.
  • Norsk Hydro ASA
  • ThyssenKrupp AG
  • MORE

Abstract
On Feb. 3 Rautaruukki Corp., a major Finnish steel construction and engineering company, disappointed investors with its fourth-quarter report. Rautaruukki's shares dropped 4% the day after the company said that its fourth-quarter net loss of €30 million fell short of the consensus estimate of a €19 million profit (see chart 1). Share price and its volatility is one of the influential components of the Risk-to-Price (R2P) scoring model. R2P measures on a relative basis how well a given security compensates investors, through yield, for underlying market and credit risks. The first quartile contains the highest-scoring issues, which best compensate investors for underlying risks; the lowest scores rank in the fourth quartile. Having digested this disappointing earnings report and investors' negative...

Companies mentioned in this report are:
- Norsk Hydro ASA
- BHP Billiton Finance Ltd.
- ThyssenKrupp AG
- ThyssenKrupp Finance Nederland B.V.
- Arcelor S.A.
- Anglo American Capital PLC
- ArcelorMittal Finance
- Glencore Finance (Canada) Limited

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international READ MORE >

Note: Product cover images may vary from those shown

- Norsk Hydro ASA
- BHP Billiton Finance Ltd.
- ThyssenKrupp AG
- ThyssenKrupp Finance Nederland B.V.
- Arcelor S.A.
- Anglo American Capital PLC
- ArcelorMittal Finance
- Glencore Finance (Canada) Limited

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.